Sage Therapeutics Cuts Workforce by One-Third Amid Clinical Trial Challenges

Sage Therapeutics, a biopharmaceutical company focused on developing innovative treatments for mental health disorders, has announced significant workforce reductions, eliminating approximately one-third of its employees. This announcement comes in the wake of disappointing results from recent clinical trials for its experimental therapies, which have prompted the company to reassess its operational strategy.

Continue reading